Can you imagine living 11 years with a life-threatening disease you didn’t know you had? For Walt, that’s how long it took to learn that his symptoms were caused by transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, life-threatening condition that affects the heart and is associated with heart failure. Read More

Transthyretin (trans-thy-re-tin) Amyloid Cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease. It’s characterized by deposits of amyloid protein fibrils in the walls of the left ventricle, the main pumping chamber of the heart. In ATTR-CM, the amyloid protein is made of transthyretin. Read More

Hypertrophic cardiomyopathy is most often caused by abnormal genes in the heart muscle. These genes cause the walls of the heart chamber (left ventricle) to contract harder and become thicker than normal. The thickened walls become stiff. This reduces the amount of blood taken in and pumped out to the body with each heartbeat. Read More

Transthyretin amyloid cardiomyopathy, or ATTR-CM, is a type of cardiac amyloidosis and an underdiagnosed cause of heart failure. Learn more about this condition, and if the symptoms sound familiar to you - or to someone you love - talk to your cardiologist.

Tune into this episode of the Heart Failure Beat: Healthy Living podcast to learn about steps necessary for achieving heart failure equity across racial and ethnic groups.